INHIBITION OF PLATELET-DEPENDENT THROMBOSIS BY LOW-MOLECULAR WEIGHT HEPARIN (CY222) - COMPARISON WITH STANDARD HEPARIN
- 1 October 1989
- journal article
- research article
- Vol. 114 (4) , 349-357
Abstract
We have compared the relative antithrombotic and antihemostatic effects of the very low molecular weight heparin CY222 with standard unfractionated heparin (SH) in a baboon model of platelet-dependent thrombosis. Thrombus formation was induced by placement of a thrombogenic device in an exteriorized femoral arteriovenous shunt under conditions of intermediate-shear blood flow. The device consisted of a collagen-coated cannular segment positioned proximal to two regions of expanded diameter exhibiting disturbed flow and stasis. Thrombus formation was measured in real time by indium 111-labeled platelet imaging. The collagen-coated surface accumulated thrombi composed largely of platelets, and the regions of disturbed flow were morphologically rich in fibrin and red cells. SH and CY222 were administered by continuous infusion for 1 hour. Although both heparin preparations abolished thrombus formation in the low-shear fibrin-rich regions at plasma levels less than 0.5 anti-Xa U/ml, platelet deposition onto the collagen surface was not reduced by either SH or CY222 at that dosage. These findings were consistent with previously observed therapeutic benefits of this level of anti-Xa activity in venous, but not arterial, thrombosis. Platelet deposition on the collagen was reduced in a dose-dependent manner by both SH and CY222 administered at doses between 1 and 5 anti-Xa U/ml. It is important to note that although heparin preparations produced profound and equivalent antithrombotic effects for platelet-dependent thrombus formation at comparable levels at anti-Xa activity, SH prolonged both the coagulation time and the bleeding time substantially more than did CY222. Thus, in this model a platelet-dependent thrombotic events, CY222 showed a much more favorable ratio of antithrombotic to antihemostatic effects than did SH.This publication has 15 references indexed in Scilit:
- Low Molecular Weight Heparin in Haemodialysis for Chronic Renal Failure: Dose Finding Study of CY222Thrombosis and Haemostasis, 1988
- Neutralization of heparin by prothrombin activation productsThrombosis Research, 1987
- THE RELATION OF PLATELET DENSITY TO PLATELET AGE - SURVIVAL OF LOW-DENSITY AND HIGH-DENSITY INDIUM-111-LABELED PLATELETS IN BABOONS1986
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Biochemical Journal, 1984
- Heparin with two binding sites for antithrombin or platelet factor 4.Journal of Biological Chemistry, 1982
- PLATELET PROTECTION AND HEPARIN SPARING WITH PROSTACYCLIN DURING REGULAR DIALYSIS THERAPYThe Lancet, 1980
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombinThrombosis Research, 1979